Illumina beats expectations in Q3, aided by sequencing consumables
Illumina Inc. crushed analysts' estimates for the third quarter, posting revenue of $794 million vs. the Street consensus of $716 million. Driving results were sequencing consumables, which racked up $500 million in the period, with clinical sequencing hitting ...
from Google Alert - Business https://ift.tt/37YcyT1
Illumina Inc. crushed analysts' estimates for the third quarter, posting revenue of $794 million vs. the Street consensus of $716 million. Driving results were sequencing consumables, which racked up $500 million in the period, with clinical sequencing hitting ... https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/37YcyT1
Illumina Inc. crushed analysts' estimates for the third quarter, posting revenue of $794 million vs. the Street consensus of $716 million. Driving results were sequencing consumables, which racked up $500 million in the period, with clinical sequencing hitting ... https://ift.tt/eA8V8J
Comments
Post a Comment